Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue 1, 2005, Pages 27-32

  Hattori, Noriko ^a   Niimi, Takashi ^a   Sato, Shigeki ^a   Achiwa, Hiroyuki ^a   Maeda, Hiroyoshi ^a   Oguri, Tetsuya ^a   Bessho, Yuji ^a   Ito, Hidemi ^a   Shimizu, Shigeki ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Cytotoxic T lymphocyte antigen 4; Polymorphism; Sarcoidosis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CTLA4 GENE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOCONJUGATES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SARCOIDOSIS; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 20144389018     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Green JM: The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am J Respir Cell Mol Biol 2000; 22: 261-4.
2. Egen JG, Kuhns MS, Allison JP: CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611-8.
3. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
4. Baughman RP, Lower EE, du Bois RM: Sarcoidosis. Lancet 2003; 361: 1111-8.
5. Nicod LP, Isler P: Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997; 17: 91-6.
6. Agostini C, Trentin L, Perin A, et al: Regulation of alveolar macrophage-T cell interactions during ThI-type sarcoid inflammatory process. Am J Physiol 1999; 277: L240-50.
7. Wahlström J, Berlin M, Sköld CM, Wigzell H, Eklund A, Grunewald J: Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54: 339-46.
8. Maurer M, Loserth S, Kolb-Mäurer A, et al: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (cxon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8.
9. Wang XB, Zhao X, Giscombe R, Lefvert AK: A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002; 3: 233-4.
10. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K: CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998; 51: 563-6.
11. Yanagawa T, Taniyama M, Enomoto S, et al: CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7: 843-6.
12. Mäurer M, Ponath A, Kruse N, Rieckmann P: CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis. J Neuroimmunol 2002; 131: 213-5.
13. Wang XB, Kakoulidou M, Qiu Q, et al: CDSI and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun 2002; 3: 46-9.
14. Giscombe R, Wang X, Huang D, Lefvert AK: Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis. J Rheumatol 2002; 29: 950-3.
15. Lee SY, Lee YH, Shin C, et al: Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocytc antigen-4 gene. Chest 2002; 122: 171-6.
16. Gambelunghe G, Ghaderi M, Cosentino A, Falorni A: CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann NY Acad Sci 2002; 958: 337-40.
17. Niimi T, Tomita H, Sato S, et al: Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 1999; 160: 1107-9.
18. Martinetti M, Luisetti M, Cuccia M: HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 83-95.
19. McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes-soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-64.
20. Niimi T, Tomita H, Sato S, et al: Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients. Chest 1998; 114: 495-9.
21. Grutters JC, Sato H, Pantelidis P, et al: Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 20-7.
22. Ohchi T, Shijubo N, Kawabata I, et al: Polymorphism of Clara cell 10-kD protein gene of sarcoidosis. Am J Respir Crit Care Med 2004; 169: 180-6.
23. Handa T, Nagai S, Ito I, et al: Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon I polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 190-6.
24. Karma A, Taskinen E, Kainulainen H, Partanen M: Phenotypes of conjunctival inflammatory cells in sarcoidosis. Br J Ophthalmol 1992; 76: 101-6.
25. Semenzato G, Agostini C, Zambello R, et al: Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations. Ann NY Acad Sci 1986; 465: 56-73.
26. Gong JH, Zhang M, Modlin RL, et al: Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996; 64: 913-8.
27. Merlo A, Saverino D, Tenca C, Grossi CE, Bruno S, Ciccone E: CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis. Infect Immun 2001; 69: 6022-9.
28. Kirman J, McCoy K, Hook S, et al: CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection. Infect Immun 1999; 67: 3786-92.